Publications

Welcome to the National Allergy Centre of Excellence (NACE) Publications Directory. As Australia's peak allergy research body, here you will find the latest evidence out of drug, food, insect and respiratory allergy studies involving our leading researchers.

• For more information about the clinical trials and cohort or registry studies underway across Australia, please visit the NACE Allergy Studies Directory.
• For NACE Postdoctoral Fellows, Postgraduate Scholars and members, please see our Publications Guidelines  about NACE affiliation and acknowledgement for people involved in research supported, conducted and/or funded by the NACE. 

• 
  Other Mar 2025

  Early-life protein-bound skin ceramides help predict the development of atopic dermatitis

  The Journal of Allergy and Clinical Immunology

  Read more

• 
  Other Mar 2025

  Emergency department presentations related to asthma and allergic diseases in Central Queensland, Australia: a comparative analysis between First Nations Australians and Australians of other descents

  Emergency department presentations related to asthma and allergic diseases in Central Queensland, Australia: a comparative analysis between First Nations Australians and Australians of other descents

  BMJ Open

  Read more

• 
  Food allergy Feb 2025

  Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE

  The Journal of Allergy and Clinical Immunology: In Practice. 

  Read more

• 
  Insect allergy Feb 2025

  Demography and baseline characteristics of individuals planned for jack jumper ant-specific venom immunotherapy at the Victorian Insect Venom Allergy Service

  The Journal of Allergy and Clinical Immunology: In Practice. 

  Read more

• 
  Respiratory allergy Jan 2025

  Aerobiology matters: Why people in the community access pollen information and how they use it

  Clinical and Translational Allergy

  Read more

• 
  Food allergy Dec 2024

  Allergen Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years

  Allergy

  Read more

• 
  Drug allergy Dec 2024

  The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round: A prospective cohort study.

  CMI Communications

  Read more

• 
  Food allergy Dec 2024

  Cost-effectiveness of Oral Immunotherapy for Egg Allergy According to Age of Therapy Commencement

  The Journal of Allergy and Clinical Immunology: In Practice. 

  Read more

• 
  Food allergy Nov 2024

  EAACI guidelines on the management of IgE-mediated food allergy

  Allergy

• 
  Respiratory allergy Nov 2024

  A global survey addressing sustainability of pollen monitoring

  World Allergy Organization Journal

  Read more

If you would like to request a PDF version of a full article, please email [email protected]